Skip to main content

Giving Tuesday is December 3, 2024!

Have we made a difference in your life this year? This Giving Tuesday, show your support and help us continue our mission!

We are here for every step of your journey.

The Cure Mito Foundation is a leading patient advocacy organization dedicated to advancing research on Leigh syndrome and other mitochondrial diseases empowering affected families worldwide. We provide opportunities to connect, learn, and find resources, strength, and courage to live your best life.

Research

The Cure Mito Foundation unites the global Leigh syndrome community to accelerate patient-centered research, treatments, and cures. We are partners on several cutting edge projects, including gene therapy, drug repurposing, and other innovative Leigh syndrome research initiatives.

LEARN MORE

About Leigh Syndrome

Leigh syndrome is the most common pediatric mitochondrial disease. It is a neurodegenerative disease causing the loss of abilities to walk, talk, swallow. Leigh syndrome can be caused by 110+ nuclear and mitochondrial DNA mutations. Approximately 1 in 40,000 are affected.

LEARN MORE

Newly Diagnosed?

If you or your loved one has been newly diagnosed, know that you are not alone. We are here to support you with resources, guidance, and a community of families who understand and are dedicated to helping you navigate this journey.

Leigh Syndrome Facts

1 in 40,000

individuals are affected

2 mo – 3 yrs

symptoms start

110+

genetic mutations

Results of a head MRI show the multiple dimensions of the human brain. Leigh Syndrome is a mitochondrial disease that impacts the brain, changes associated with the disorder can be detected via MRI.

History of Leigh Syndrome

Leigh syndrome is named after Dr. Denis Leigh, a neuropathologist in London, who first described the condition in 1951. It is characterized by specific brain lesions, which are a unique feature of the condition. These lesions typically appear in the basal ganglia, brainstem, and cerebellum. The affected areas often exhibit bilateral symmetrical necrotic or degenerative changes. These distinctive lesions are one of the key diagnostic markers used in identifying it.

LEARN MORE

Patient Registry

Join the registry to be counted no matter where you are in the world, help advance the understanding of Leigh syndrome, raise awareness for the need for treatments, and stay informed on research and clinical trial opportunities.

Global

Largest LS registry in the world, 350+ participants, 40+ countries

Accessible

Accessible and available data

Results

Results are always reported back to the community, keeping you informed

Join Registry

WHAT OTHERS ARE SAYING

“Working with Cure Mito has been such a wonderful experience. They are very professional, knowledgeable, and committed to improving diagnosis and treatment for all individuals with mitochondrial diseases. They make it their mission to have everyone they touch benefit from the interaction.”

Susan Clement

Senior Director Strategic Marketing at Saol Therapeutics

“When our daughter diagnosed, we were given zero hope or help. Finding Cure Mito was the best thing that happened to us. We found a community of parents running the work and every penny going to research. We knew this was the place for us. There are so many resources for newly diagnosed families, so many projects and ways you can get involved for your child and their specific mutation. I cannot recommend this organization enough!”

Lauren Hurt-Ashwin

Delta’s mom, Cure Mito Board Member

What’s Next?

A clipboard that can be clicked to navigate to the patient registry page

Patient Registry

A heart that can be clicked to navigate to a donation form

Donate

A megaphone that can be clicked to navigate to the get involved with cure mito page

Get Involved